FDA New, GMP Do
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
Sibutramine mesylate, 676598-10-0 ;106650-56-0 (free), Sibutramine mesylate Intermediate 140-53-4, stock 109.3g, white powder, assay by HPLC 99.6%, HNMR, LCMS we supply.
Sibutramine mesylate, 676598-10-0 ;106650-56-0 (free), Sibutramine mesylate Intermediate 109-64-8, stock 525.3g, white powder, assay by HPLC 98.8%, HNMR, LCMS we supply.
Sibutramine mesylate, 676598-10-0 ;106650-56-0 (free), Sibutramine mesylate Intermediate 28049-61-8, stock 701.1g, white powder, assay by HPLC 98.7%, HNMR, LCMS we supply.
Sibutramine mesylate, 676598-10-0 ;106650-56-0 (free), Sibutramine mesylate Intermediate 926-62-5, stock 916.1g, white powder, assay by HPLC 98.4%, HNMR, LCMS we supply.
Sibutramine mesylate, 676598-10-0 ;106650-56-0 (free), Sibutramine mesylate Intermediate 84467-54-9, stock 853.4g, white powder, assay by HPLC 100%, HNMR, LCMS we supply.
Sibutramine mesylate, 676598-10-0 ;106650-56-0 (free), Sibutramine mesylate Intermediate 106650-56-0, stock 626.8g, white powder, assay by HPLC 99.9%, HNMR, LCMS we supply.
